echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > International Chemical > Evonik launches non-animal collagen platform

    Evonik launches non-animal collagen platform

    • Last Update: 2022-09-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, Evonik announced that the company's recombinant non-animal-derived collagen platform Vecollan was officially commercialized


    Evonik said that Vecollan is a new differentiated system solution specially designed by Evonik for the medical device industry, and is provided to customers through the Evonik Medical Device Technology Centers in Birmingham, Alabama, Darmstadt, Germany and Shanghai, China.


    According to Evonik, animal-derived collagen is currently mainly used in the life science and pharmaceutical fields, so there are quality differences between different batches, the transmission of potential diseases or pathogens, and the possibility of causing adverse immune reactions or allergic reactions




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.